InspireMD Schedules Second Quarter 2018 Earnings Conference Call
Tel Aviv – July 31, 2018 – InspireMD, Inc. (NYSE: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it will host a conference call on Tuesday, August 7th at 8:00 a.m. Eastern Time to discuss the company’s financial results for the second quarter ended June 30, 2018, as well as the Company’s corporate progress and other meaningful developments.
The conference call will be available via telephone by dialing toll free 877-407-0782 for U.S. callers or +1 201- 689-8567 for international callers, or on the Company’s Investor Relations section of the website: https://www.inspiremd.com/en/investors/investor-relations/
A webcast will also be archived on the Company’s website and a telephone replay of the call will be available approximately one hour following the call, through August 21, 2018 until 8:00 am ET, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering conference ID: 36394.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™® technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events. InspireMD intends to pursue applications of this MicroNet™® technology in coronary, carotid (CGuard™), neurovascular, and peripheral artery procedures. Additional information about the Company is available at: www.inspiremd.com.
Investor Contacts:
InspireMD, Inc.
Craig Shore
Chief Financial Officer
Phone: 1-888-776-6804 FREE
Email: craigs@inspiremd.com
Crescendo Communications, LLC
David Waldman
Phone: (212) 671-1021
Email: NSPR@crescendo-ir.com